
The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

